145 related articles for article (PubMed ID: 4049531)
1. Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.
Banks J; Jenkins PA; Smith AP
Tubercle; 1985 Sep; 66(3):197-203. PubMed ID: 4049531
[TBL] [Abstract][Full Text] [Related]
2. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
Research Committee of the British Thoracic Society
Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium malmoense in the north-east of England.
Connolly MJ; Magee JG; Hendrick DJ; Jenkins PA
Tubercle; 1985 Sep; 66(3):211-7. PubMed ID: 4049533
[TBL] [Abstract][Full Text] [Related]
4. A ten-year clinical experience with Mycobacterium kansasii.
Rauscher CR; Kerby G; Ruth WE
Chest; 1974 Jul; 66(1):17-9. PubMed ID: 4846114
[No Abstract] [Full Text] [Related]
5. Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii.
Harris GD; Johanson WG; Nicholson DP
Am Rev Respir Dis; 1975 Jul; 112(1):31-6. PubMed ID: 1147382
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of tuberculosis.
Harris AA; Karakusis P
Prim Care; 1979 Mar; 6(1):43-62. PubMed ID: 111269
[No Abstract] [Full Text] [Related]
7. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium malmoense infections in Scotland: an increasing problem.
France AJ; McLeod DT; Calder MA; Seaton A
Thorax; 1987 Aug; 42(8):593-5. PubMed ID: 3660312
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
Jenkins PA; Campbell IA;
Respir Med; 2003 Apr; 97(4):439-44. PubMed ID: 12693807
[TBL] [Abstract][Full Text] [Related]
10. Response to chemotherapy of pulmonary infection due to mycobacterium kansasii.
Harris GD; Johnason WG; Nicholson D
Bull Int Union Tuberc; 1976; 51(1):275-8. PubMed ID: 1030296
[No Abstract] [Full Text] [Related]
11. Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
Thorax; 1994 May; 49(5):442-5. PubMed ID: 8016763
[TBL] [Abstract][Full Text] [Related]
12. The Australian rifampicin trial.
Proust A; Evans C
Med J Aust; 1972 Oct; 2(16):861-7. PubMed ID: 4647286
[No Abstract] [Full Text] [Related]
13. [Place of bacteriological examination in the treatment of tuberculosis].
Gyselen A
Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
[No Abstract] [Full Text] [Related]
14. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
15. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448
[TBL] [Abstract][Full Text] [Related]
16. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.
Banks J; Hunter AM; Campbell IA; Jenkins PA; Smith AP
Thorax; 1983 Apr; 38(4):271-4. PubMed ID: 6867979
[TBL] [Abstract][Full Text] [Related]
18. First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons.
Coninx R; Mathieu C; Debacker M; Mirzoev F; Ismaelov A; de Haller R; Meddings DR
Lancet; 1999 Mar; 353(9157):969-73. PubMed ID: 10459906
[TBL] [Abstract][Full Text] [Related]
19. The results of 9-month isoniazid-rifampin therapy for pulmonary tuberculosis under program conditions in San Francisco.
Slutkin G; Schecter GF; Hopewell PC
Am Rev Respir Dis; 1988 Dec; 138(6):1622-4. PubMed ID: 3144221
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
